Vattipally B Sreenu Selected Research

Viremia

6/2015

HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vattipally B Sreenu Research Topics

Disease

9	Infections 10/2023 - 04/2014
2	Hepatitis C 01/2019 - 09/2013
1	Coinfection 07/2023
1	COVID-19 01/2021
1	Chronic Hepatitis B 01/2020
1	Viremia 06/2015
1	Disease Progression 04/2014

Drug/Important Bio-Agent (IBA)

3	Antiviral Agents (Antivirals)IBA 07/2023 - 01/2019
2	Small Interfering RNA (siRNA)IBA 10/2023 - 12/2018
2	RNA (Ribonucleic Acid)IBA 07/2023 - 12/2018
2	Ribonuclease III (RNase III)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
1	NucleotidesIBA 01/2023
1	Amino Acids FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Tenofovir (Viread)FDA Link 01/2020
1	Biological Control AgentsIBA 12/2018
1	Piwi-Interacting RNAIBA 12/2018
1	gag Gene Products (gag Protein)IBA 06/2015
1	EpitopesIBA 04/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2013

Therapy/Procedure

1	Critical Care (Surgical Intensive Care) 01/2021